Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Selective monoacylglycerol lipase inhibitor improves experimental MS

Sep. 26, 2014

MIS-416 treatment enhances systemic negative regulators of inflammation in patient plasma

Sep. 26, 2014

Mutation identified in a patient with hyperlysinemia

Sep. 26, 2014

Asfotase alfa shows benefit in phase II trials in pediatric patients with hypophosphatasia

Sep. 26, 2014

Identification of SARMs that can be administered transdermally

Sep. 26, 2014

Viable mouse models of methylmalonic acidemia created

Sep. 25, 2014

Merck & Co. presents results for MK-0674 in ovariectomized cynomolgus monkeys

Sep. 25, 2014

Newly identified genetic variations linked to riboflavin-responsive MADD disorder

Sep. 25, 2014

New synthetic anti-TB drug from a rediscovered natural cyclic peptide

Sep. 25, 2014

Researchers describe the function of MS susceptibility gene

Sep. 25, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...